Get Started

CLRPF

PINK Clarity Pharmaceuticals Ltd.
Oct 26, 2026 · 9:30 AM ET EOD Market Open

$1.12 ↑ +0.00 (+0.00%) Trading Up from the previous close of $1.12, $0.12 below the day’s high of $1.23

YTD change
-50.84%
vs 20-day SMA
-22.84%
vs 200-day SMA
-48.07%

Price ranges

Previous day
$1.12 $1.23
open $1.23 close $1.12
-$0.12 (-9.35%)
Today
$1.12 $1.23
open $1.23 now $1.12
-$0.12 (-9.35%)
Past week
$1.25 $1.34
from $1.34 now $1.12
-$0.22 (-16.59%)
Past month
$1.25 $1.69
from $1.69 now $1.12
-$0.58 (-34.02%)
This year
$1.12 $2.89
from $2.27 now $1.12
-$1.15 (-50.84%)

Price & Performance

-1.05 (-48.38%) / 6M

$1.02$1.46$1.90$2.34Apr 27Jul 9Oct 23

Signals & Sentiment

Momentum, market sentiment, and recent alerts

N/A
  • The stock is 82.6% away from all-time highs of $6.40
  • CLRPF is down 51% since the beginning of the year
  • CLRPF is down 65% over the past 12 months
  • CLRPF is down 34% over the past 1 month
  • 2% of all CLRPF investors are betting against CLRPF

CLRPF reads n/a: price sits below both the 20- and 200-day averages, the 12-month move is -62.6%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable N/A
EPS N/A
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Beta 3.42

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$123.5M
DebtN/A
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangePINK
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $416.0M

Clarity Pharmaceuticals Ltd. is a clinical stage radiopharmaceutical company. It engages in research and development and clinical stage evaluation of its portfolio of novel radiopharmaceuticals products. The company was founded by Matthew Harris on April 8, 2010 and is headquartered in Eveleigh, Australia.

Competitor comparison

TickerCompany PriceChange
ARGNF argenx SE $790.15 -15.58%
GNNSF Genscript Biotech Corporation $4.25 +1.80%
GLXY Galaxy Digital Inc. Class A $14.68 -3.99%
PVLA Palvella Therapeutics, Inc. $125.10 -1.02%
EPRX Eupraxia Pharmaceuticals, Inc. $6.87 -9.49%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.